Klastersky J
Service de Médecine, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Belgium.
Support Care Cancer. 1994 Nov;2(6):347-54. doi: 10.1007/BF00344047.
Infection in neutropenic patients remains a continuing challenge as the modalities of cancer treatment evolve and new pathogens appear. Although the concept of empirical therapy remains valid, there is a need for adaptation of our therapeutic approaches to new clinical and microbiological evidence.
随着癌症治疗方式的演变以及新病原体的出现，中性粒细胞减少患者的感染仍然是一个持续存在的挑战。尽管经验性治疗的概念仍然有效，但我们需要根据新的临床和微生物学证据调整治疗方法。
